Risk of valvular heart disease after treatment for Hodgkin lymphoma
about
Novel concepts in radiation-induced cardiovascular disease.Radiation and Circulatory DiseaseData taken from the review article "Radiation and circulatory disease" and used in the associated meta-analysis.Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclinesCardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.Cardiotoxicity Following Cancer Treatment.Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.A cardiac contouring atlas for radiotherapyEffect of accurate heart delineation on cardiac dose during the CONVERT trial.The concept and evolution of involved site radiation therapy for lymphoma.Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic trainingRadiation-induced valvular heart disease.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?Radiation Toxicity to the Cardiovascular System.Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.Short and long term radiation induced cardiovascular disease in patients with cancer.Radiation-Induced Cardiovascular Disease.Valvular Heart Disease in Cancer Patients: Etiology, Diagnosis, and Management.Late sequelae in Hodgkin lymphoma survivors.The continued conundrum of Hodgkin lymphoma etiology.Radiation-Induced Cardiovascular Disease: A Clinical Perspective.Cardiovascular effects of Hodgkin's lymphoma: a review of literature.Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold.Cancer and heart disease: new bedfellows in the cardiovascular landscape.High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.Sestrin2 protects the myocardium against radiation-induced damage.Occult constrictive pericardial disease emerging 40 years after chest radiation therapy: a case report.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice GuidelinesLong-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis
P2860
Q28071302-4DB04680-D48E-4907-B6B8-6779E2E52FF2Q29248999-D4B9D02B-EE3D-4FFC-B388-79B2A592B12EQ31145529-66BC4C02-48EA-40D5-A098-E1097964D21EQ33640172-08514E1B-B71B-45D0-8B76-F63C4221AE8EQ37409640-98D9AFEF-E8DD-42B8-9711-7B9F5BD61382Q37663263-A6E887C3-A326-4976-969D-BB4BEEC373EDQ37682745-23022798-A492-4808-BE0F-3C83151ED399Q37708633-515B1922-4158-4031-AE95-7F15EF2D8A77Q38378765-F38975A2-9A7C-4DFE-8B11-67F5DB009486Q38543470-32D2E3FA-82CE-47C7-8644-B03C0F1EEBCEQ38559153-BA6E3723-1318-47BD-9709-A2827DFC5FE1Q38667723-6842C3D2-D3D5-4F66-9DF8-64A6C10FCC49Q38688797-A6ECEC18-4C67-47FB-AA4B-7A015C292640Q38720780-8B993586-ABE4-4B86-94CD-03403BB090F7Q38836695-B21B9088-6A62-425D-8AE5-F35B596AB4B7Q38904546-7D04937F-474A-4DE6-AF9E-F0A538EB9ED8Q39111249-4BE4802D-8800-4FEB-AC29-A2C350A35BA3Q39185680-46D8A0EB-83F4-4887-8516-DCEBE2996F12Q39332072-489E21F0-B3C3-4DAD-8268-D9F5EECBF5C1Q40168935-7EB00B9B-D8A0-43BA-A65E-01BD0024C4EFQ41735742-8B98E1AA-EF1C-4D4B-BA5A-B9F2E7E233CAQ45072741-030D51EF-F33D-4669-9B6A-8CCCF56F96E2Q47236177-EAEA55BF-76B0-40EF-9161-29DDD64120F0Q47639244-B2922133-1939-4619-832B-E9BB8CB61B18Q47793582-D8570A8A-E4DC-43D6-BC68-4203C75106B0Q47793785-EF5F6F95-B49E-4966-B369-5DAFDB508C85Q49578208-1FF04A60-E16A-4B00-99F4-12BC49E5661EQ53146958-70154357-2D1F-4F50-8EDD-BEDB87A64C9AQ55024098-E7AA8CCE-BF7F-4FF9-AD91-0103D05C3570Q57057499-74034951-6EA5-4204-85C6-DB8EEC0DB5E6Q58775872-E05B9C32-A42F-4980-BC40-9CD2AEF78EAF
P2860
Risk of valvular heart disease after treatment for Hodgkin lymphoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@ast
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@en
type
label
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@ast
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@en
prefLabel
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@ast
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@en
P2093
P2860
P50
P356
P1476
Risk of valvular heart disease after treatment for Hodgkin lymphoma
@en
P2093
Berthe M P Aleman
Cecile P M Janus
David J Cutter
Flora E van Leeuwen
Frederika A van Nimwegen
Sarah C Darby
P2860
P356
10.1093/JNCI/DJV008
P407
P577
2015-02-23T00:00:00Z